MicroRNA-34a: the bad guy in age-related vascular diseases

MicroRNA-34a: the bad guy in age-related vascular diseases

The age-related vasculature alteration is the prominent risk factor for vascular diseases (VD), namely, atherosclerosis, abdominal aortic aneurysm, vascular calcification (VC) and pulmonary arterial hypertension (PAH). The chronic sterile low-grade inflammation state, alias inflammaging, characteriz...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Raucci, A, Macrì, F, Castiglione, S, Badi, I, Vinci, MC, Zuccolo, E
Format:	Journal article
Język:	English
Wydane:	Springer 2021

Podobne zapisy

MicroRNA-34a role in vascular calcification
od: Badi, I, i wsp.
Wydane: (2016)

Bad guy or good guy? The framing of an imam
od: Regula Hänggli Fricker, i wsp.
Wydane: (2022-12-01)

Must Dentists Be the “Bad Guy?”
od: Benjamin W. Chaffee
Wydane: (2024-12-01)

MicroRNA-34, microRNA-130, microRNA-148, microRNA-181, microRNA-194 and microRNA-605 expression in colon cancer tissue
od: D. I. Azovsky, i wsp.
Wydane: (2024-03-01)

Misi Menantu Mr Bad Guy /
od: Ailah Diela, 1988-, author 638179
Wydane: (2015)

Misi Cinta Mr. Bad Guy /
od: Ailah Diela, 1988-, author 638179
Wydane: (2014)

Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
od: Ana Luiza Normanha Ribeiro de Almeida, i wsp.
Wydane: (2016-01-01)

Editorial: Biological invaders: Always the bad guys?
od: Bruce Arthur Osborne, i wsp.
Wydane: (2022-11-01)

MicroRNA regulation of vascular function
od: David Mellis, i wsp.
Wydane: (2019-07-01)

MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment
od: Wei-Hong Kuang, i wsp.
Wydane: (2018-05-01)

MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact
od: Meik Kunz, i wsp.
Wydane: (2017-07-01)

Are Investors the Bad Guys? Tenure and Neighborhood Stability in Chelsea, Massachusetts
od: Fisher, Lynn M., i wsp.
Wydane: (2013)

Fibroblast growth factor 2: good or bad guy in the joint?
od: Vincent, T
Wydane: (2011)

Bad Guys and Bag Ladies: On the Politics of Polemics and the Promise of Ambivalence
od: Taina Bucher
Wydane: (2019-07-01)

p53/MicroRNA-34 axis in cancer and beyond
od: Wei Pan, i wsp.
Wydane: (2023-04-01)

Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
od: Bianca C. Bernardo, i wsp.
Wydane: (2018-09-01)

Beware of the ‘Bad Guys’: Economic Inequality, Perceived Competition, and Social Vigilance
od: Lei Cheng, i wsp.
Wydane: (2021-04-01)

MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
od: Ying Zhang, i wsp.
Wydane: (2014-01-01)

MicroRNA-34a: A Novel Therapeutic Target in Fibrosis
od: Min Zhao, i wsp.
Wydane: (2022-06-01)

MicroRNA-34 and gastrointestinal cancers: a player with big functions
od: Wei Gao, i wsp.
Wydane: (2024-05-01)

MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44
od: Gan Yu, i wsp.
Wydane: (2014-12-01)

An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a
od: Serviss, J, i wsp.
Wydane: (2018)

MicroRNA Profiling in Cartilage Ageing
od: Panagiotis Balaskas, i wsp.
Wydane: (2017-01-01)

MicroRNA‐34a‐Dependent Attenuation of Angiogenesis in Right Ventricular Failure
od: Sushma Reddy, i wsp.
Wydane: (2024-02-01)

Application of microRNA-34a for diagnosis of pleomorphic adenomas of salivary glands
od: I. S. Brodetskyi, i wsp.
Wydane: (2019-10-01)

miR-34 – A microRNA Replacement Therapy Is Headed to the Clinic
od: Andreas G Bader
Wydane: (2012-07-01)

Expression of miR-34 family of microRNA and clinical outcome of neuroblastoma
od: M. Inomistova, i wsp.
Wydane: (2016-09-01)

MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell
od: Narjes Jafari, i wsp.
Wydane: (2017-04-01)

microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
od: Claudio de Lucia, i wsp.
Wydane: (2017-06-01)

Non-state Actors in the International System: How Do We Recognize the Bad Guys?
od: Miroslav Plundrich
Wydane: (2022-11-01)

Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the "bad guy"?
od: Neher Miriam D, i wsp.
Wydane: (2011-11-01)

High Phosphate-Induced JAK-STAT Signalling Sustains Vascular Smooth Muscle Cell Inflammation and Limits Calcification
od: Federica Macrì, i wsp.
Wydane: (2023-12-01)

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
od: Lu Zhang, i wsp.
Wydane: (2019-02-01)

Role of microRNA miR-34a in liver cancer stem cells
od: Lu-Lu Gong, i wsp.
Wydane: (2016-03-01)

MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ.
od: Jinwook Shin, i wsp.
Wydane: (2013-01-01)

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
od: Cun-Cun Hua, i wsp.
Wydane: (2022-01-01)

MicroRNA-34a is a potent tumor suppressor molecule <it>in vivo </it>in neuroblastoma
od: Alcock Leah C, i wsp.
Wydane: (2011-01-01)

Increased microRNA-34c abundance in Alzheimer’s disease circulating blood plasma
od: Shephali eBhatnagar, i wsp.
Wydane: (2014-02-01)

Vascular calcification: Role of vascular smooth muscle cells and its regulation by microRNA
od: Abeer H. Amer, i wsp.
Wydane: (2021-01-01)

Development of microRNA therapeutics is coming of age
od: Eva van Rooij, i wsp.
Wydane: (2014-06-01)